Sign in

Note: the SXRNSCLC-PRSP software is a predictive tool designed to assess prognostic risk and survival outcomes for patients with resected non-small cell lung cancer (NSCLC) classified as T_1-3N_0-2M₀(according to the 9th AJCC/UICC TNM stage of lung cancer) in Shanxi Province, China. Clinicians can input patient data into the software to receive prognostic outputs including the estimates of the restrictive mean survival time(RMST) and 1-5 year survival rate, helping in tailoring follow-up care, adjuvant therapy, and clinical trial eligibility. The software is applicable to the following conditions: 1. Patients aged 20 or above; 2. No history of hypertension; 3. Han ethnicity; 4. Tumor stage II or III; 5. Tumor pathology: adenocarcinoma; 6. Tumor located in the left or right lung; 7. Tumor located in the upper or down lobe; 8. Married patients; 9. Surgical methods: LET, PPET or PET.

Abbreviation: TNM=Tumor Node Metastasis
                        NSCLC=non-small cell lung cancer
                        AJCC=American Joint Committee on Cancer
                        UICC= Union for International Cancer Control
                        RMST=Restricted mean survival time
                        LET= Lobectomy
                        PPET= Partial pneumonectomy
                        PET= Pneumonectomy

new user register

Feedback